Designs, manufactures, and markets medical device products and systems. Provides products for acute and chronic respiratory care. Now — the numbers.
This is an established company with proven profits.
Average growth of 10% a year over the last 4 years. Every year shown ended in profit.
If every debt were paid off today, $185.9M would still be left — though next to the size of the company that is a thin cushion.
The market pays 55× for every dollar this company earns in a year — a price that already assumes things go well.
Analysts' average target sits 8% below today's price.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
The net profit margin is 20% — still a thick cushion, though costs have been eating into it lately.
Over the last 4 years, sales grew about 10% a year on average.
There is $270.9M in the vault; even if every debt were paid off, $185.9M would remain.
The company’s market value is 55 times its annual profit. Even a small disappointment could hit the price hard.
The price action doesn’t yet back an upward turn. Council score: 0/10.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: the revenue breakdown.